The effects of anti-angiogenic therapy on the formation of radiation-induced microbleeds in normal brain tissue of patients with glioma. Read more about The effects of anti-angiogenic therapy on the formation of radiation-induced microbleeds in normal brain tissue of patients with glioma.
BT-07MEASURING TUMOR METABOLISM IN DIFFUSE INTRINSIC PONTINE GIOMAS (DIPG) USING HYPERPOLARIZED CARBON-13 MR SPECTROSCOPIC IMAGING. Read more about BT-07MEASURING TUMOR METABOLISM IN DIFFUSE INTRINSIC PONTINE GIOMAS (DIPG) USING HYPERPOLARIZED CARBON-13 MR SPECTROSCOPIC IMAGING.
Telomere maintenance and the etiology of adult glioma. Read more about Telomere maintenance and the etiology of adult glioma.
Toward precision medicine in glioblastoma: the promise and the challenges. Read more about Toward precision medicine in glioblastoma: the promise and the challenges.
Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors. Read more about Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors.
Response to "the epidemiology of glioma in adults: a 'state of the science' review". Read more about Response to "the epidemiology of glioma in adults: a 'state of the science' review".
Sui generis: gene therapy and delivery systems for the treatment of glioblastoma. Read more about Sui generis: gene therapy and delivery systems for the treatment of glioblastoma.
Convection-enhanced delivery for the treatment of glioblastoma. Read more about Convection-enhanced delivery for the treatment of glioblastoma.
A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study. Read more about A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study.
ET-29AN OPTIMIZED ONCOLYTIC ADENOVIRUS FOR GLIOMA THERAPY: SPECIFIC TARGETING, EFFICIENT INFECTION, AND RESTRICTED REPLICATION IN GLIOMA. Read more about ET-29AN OPTIMIZED ONCOLYTIC ADENOVIRUS FOR GLIOMA THERAPY: SPECIFIC TARGETING, EFFICIENT INFECTION, AND RESTRICTED REPLICATION IN GLIOMA.
